| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.02T | 2.95T | 2.35T | 1.85T | 1.58T | 1.61T |
| Gross Profit | 2.05T | 2.01T | 1.60T | 1.29T | 989.30B | 964.98B |
| EBITDA | 1.01T | 1.65T | 635.04B | 488.90B | 280.08B | 218.35B |
| Net Income | 528.91B | 510.29B | 442.56B | 340.37B | 251.10B | 183.84B |
Balance Sheet | ||||||
| Total Assets | 26.69T | 26.42T | 23.64T | 19.58T | 17.53T | 15.74T |
| Cash, Cash Equivalents and Short-Term Investments | 1.97T | 2.38T | 1.90T | 1.64T | 2.14T | 1.82T |
| Total Debt | 2.15T | 2.04T | 2.01T | 1.84T | 1.59T | 1.40T |
| Total Liabilities | 23.23T | 23.13T | 20.94T | 17.37T | 15.65T | 14.07T |
| Stockholders Equity | 3.30T | 3.14T | 2.56T | 2.14T | 1.82T | 1.58T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 773.94B | 1.54T | 552.00B | 777.05B | 1.36T |
| Operating Cash Flow | 0.00 | 822.20B | 1.57T | 577.21B | 795.97B | 1.38T |
| Investing Cash Flow | 0.00 | -2.37T | -1.46T | -2.53T | -1.94T | -629.87B |
| Financing Cash Flow | 0.00 | 2.06T | 137.65B | 1.47T | 1.51T | -546.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $101.08B | 9.08 | 21.64% | 9.77% | 11.82% | 3.41% | |
72 Outperform | $89.23B | 10.18 | 11.88% | 3.11% | 1.79% | 30.93% | |
69 Neutral | $99.83B | 18.92 | 15.95% | 0.85% | 10.85% | 7.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $131.55B | 21.06 | 13.09% | 3.03% | -1.78% | 0.65% | |
64 Neutral | $79.08B | 12.62 | 9.93% | 3.19% | -20.94% | -18.71% | |
57 Neutral | $105.62B | 10.79 | 9.73% | 2.31% | -2.84% | 25.48% |